Debra Miller, President & CEO, CureDuchenne

Video Overview

Debra Miller, founder of the charity CureDuchenne, discusses how a strategy of “venture philanthropy” – essentially the direct investment of charitable funds into early-stage companies, in exchange for equity – has enabled her organisation to support research and translation of a portfolio of multiple candidate genetic and cell therapies for a rare and devastating pediatric disease despite very limited initial funding.